href:http://www.biospectator.com/view/news_view.php?varAtcId=11681&fbclid=IwAR10Bt86aYDyoub47Nhj1jUvSBuXZowatGgcPnpMsJTCL1V6DnAiCLqFOmE

Amyloidsolution, acquisition of AI biotech company Deargen, speeding up the development of new drug for AD

Amyloidsolution, acquisition of Deargen, speeding up the development of new drug for AD.

알츠하이머병 치료제 신약개발 기업인 아밀로이드솔루션(Amyloid Solution)이 인공지능(AI) 기반 신약개발 전문기업인 디어젠(Deargen)을 인수했다.